Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., Cho, E.K., Dallaire, S., Freeman, J.L., González, J.R., Gratacòs, M., Huang, J., Kalaitzopoulos, D., Komura, D., MacDonald, J.R., Marshall, C.R., Mei, R., Montgomery, L., Nishimura, K., Okamura, K., Shen, F., Somerville, M.J., Tchinda, J., Valsesia, A., Woodwark, C., Yang, F., Zhang, J., Zerjal, T., Zhang, J., Armengol, L., Conrad, D.F., Estivill, X., Tyler-Smith, C., Carter, N.P., Aburatani, H., Lee, C., Jones, K.W., Scherer, S.W., and Hurles, M.E. (2006). Global variation in copy number in the human genome. Nature, 444, 444-454.

Reinwald, S., and Weaver, C.M. (2006). Soy isoflavones and bone health: A double-edged sword? Journal of Natural Products, 69(3), 450-459.

Ross, S.A. (2003). Diet and DNA methylation interactions in cancer prevention. Annals of the New York Academy of Sciences, 983, 197-207.

Schatzkin, A., and Gail, M. (2002). The promise and peril of surrogate end points in cancer research. Nature Reviews Genetics, 2, 1-9.

Scheuner, M.T. (2001). Genetic predisposition to coronary artery disease. Current Opinion in Cardiology, 16(4), 251-260.

Singer, P.A., and Daar, D.A. (2001). Harnessing genomics and biotechnology to improve global health equity. Science, 294, 87-89.

Slattery, M.L., Neuahusen, S.L., Hoffman, M., Caan, B., Curtin, K., Ma, K.N., and Samowitz W. (2004). Dietary calcium, vitamin D, VDR genotypes, and colorectal cancer. International Journal of Cancer, 111, 750-756.

Stover, P. (2006). Influence of human genetic variation on nutritional requirements. American Journal of Nutrition, 83(Suppl.), 436S-442S.

Thomas, J.C., Irwin, D.E., Shaugnessy Zuiker, E., and Millikan, R.C. (2005). Genomics and the public health code of ethics. American Journal of Public Health, 95(12), 2139-2143.

Thomas, T., Gallo, M.A., and Thomas, T.J. (2004). Estrogen receptors as targets for drug development for breast cancer, osteoporosis, and cardiovascular diseases. Current Cancer Drug Targets, 4(6), 483-499.

Trujillo, E., Davis, C., and Milner, J. (2006). Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. Journal of the American Dietetic Association, 106, 403-413.

Uusitupa, M.I., Ruuskanen, E., Makinen, E., Laitinen, J., Toskala, E., Kervinen, K., and Kesaniemi, Y.A. (1992). A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: Relation to apolipoprotein E phenotype. Journal of the American College of Nutrition, 11(6), 651-659.

van Erk, M.J., Blom, W.A.M., van Ommen, B., and Hendriks, H.F.J. (2006). High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. American Journal of Clinical Nutrition, 84, 1233-1241.

Viguerie, N., Poitou, C., Cancello, R., Stich, V., Clement, K., and Langin, D. (2005, January). Transcriptomics applied to obesity and caloric restriction. La biochimie, 87(1), 117-123.

Warren, A.J., and Shields, P.G. (1997). Molecular epidemiology: Carcinogen-DNA adducts and genetic susceptibility. Proceedings of the Society for Experimental Biology and Medicine, 216, 172-180.

Way, T.D., Kao, M.C., and Lin, J.K. (2004). Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. Journal of Biological Chemistry, 279(6), 4479-4489.

Wiedmann, M.W., and Caca, K. (2005). Molecularly targeted therapy for gastrointestinal cancer. Current Cancer Drug Targets, 5(3), 171-193.

Wong, H.L., Seow, A., Arakawa, K., Lee, H.P., Yu, M.C., and Ingles, S.A. (2003). Vitamin DVitamin D receptor start codon polymorphism and colorectal cancer risk: Effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis, 24, 1091-1095.